Liposome-based delivery of a boron-containing cholesteryl ester for high-LET particle-induced damage of prostate cancer cells: A boron neutron capture therapy study

References

• Alanazi F, Li HG, Halpern DS, Oie S, Lu DR. 2003. Synthesis, preformulation and liposomal formulation of cholesteryl carborane esters with various fatty chains. Int J Pharmaceut 255:189–197.
   PubMedGoogle Scholar
• Barth RF. 2003. A critical assessment of boron neutron capture therapy: An overview. J Neurooncol 62:1–5.
   PubMed Web of Science ®Google Scholar
• Barth RF. 2009. Boron neutron capture therapy at the crossroads: Challenges and opportunities. Appl Radiat Isotopes 67:S3–S6.
   PubMed Web of Science ®Google Scholar
• Burgett E, Hertel N, Blue T, Chenkovich J, Talnagi J. 2009. Neutron spectral measurement of the Ohio state research reactor pneumatic tube. J Radioanalyt Nuclear Chem 282:187–191.
   Google Scholar
• Burns WG, Sims HE. 1981. Effect of radiation type in water radiolysis. J Chem Soc, Faraday Transact 1:Phys Chem Condensed Phases 77:2803–2813.
   Google Scholar
• Chen YF, Hughes-Fulford M. 2001. Human prostate cancer cells lack feedback regulation of low-density lipoprotein receptor and its regulator, SREBP2. Int J Cancer 91:41–45.
   PubMed Web of Science ®Google Scholar
• Dagrosa MA, Crivello M, Perona M, Thorp S, Santa Cruz GA, Pozzi E, Casal M, et al. 2011. First evaluation of the biologic effectiveness factors of boron neutron capture therapy (BNCT) in a human colon carcinoma cell line. Int J Radiat Oncol Biol Phys 79:262–268.
   PubMedGoogle Scholar
• Fairchild RG, Kahl SB, Laster BH, Kalef-Ezra J, Popenoe EA. 1990. In vitro determination of uptake, retention, distribution, biological efficacy, and toxicity of boronated compounds for neutron capture therapy: A comparison of porphyrins with sulfhydryl boron hydrides. Cancer Res 50:4860–4865.
   PubMed Web of Science ®Google Scholar
• Hall EJ, Giaccia AJ. 2006. Radiobiology for the radiologist. Philadelphia, PA: Lippincott Williams and Wilkins.
   Google Scholar
• Hawthorne MF, Shelly K. 1997. Liposomes as drug delivery vehicles for boron agents. J Neurooncol 33:53–58.
   PubMed Web of Science ®Google Scholar
• Haylett AK, Moore JV. 2002. Comparative analysis of foetal calf and human low density lipoprotein: Relevance for pharmacodynamics of photosensitizers. J Photochem Photobiol B 66: 171–178.
   PubMedGoogle Scholar
• Heber EM, Kueffer PJ, Lee MW, Hawthorne MF, Garabalino MA, Molinari AJ, Nigg DW, et al. 2012. Boron delivery with liposomes for boron neutron capture therapy (BNCT): Biodistribution studies in an experimental model of oral cancer demonstrating therapeutic potential. Radiat Environ Biophys 51:195–204.
   PubMedGoogle Scholar
• Ji B, Peacock G, Lu DR. 2002. Synthesis of cholesterol-carborane conjugate for targeted drug delivery. Bioorg Med Chem Lett 12: 2455–2458.
   PubMedGoogle Scholar
• Kader A, Davis PJ, Kara M, Liu H. 1998. Drug targeting using low density lipoprotein (LDL): Physicochemical factors affecting drug loading into LDL particles. J Control Release 55:231–243.
   PubMed Web of Science ®Google Scholar
• Lai MZ, Duzgunes N, Szoka FC. 1985. Effects of replacement of the hydroxyl group of cholesterol and tocopherol on the thermotropic behavior of phospholipid membranes. Biochemistry 24:1646–1653.
   PubMed Web of Science ®Google Scholar
• Matsumura A, Shibata Y, Yamamoto T, Yoshida F, Isobe T, Nakai K, Hayakawa Y, et al. 1999. A new boronated porphyrin (STA-BX909) for neutron capture therapy: An in vitro survival assay and in vivo tissue uptake study. Cancer Lett 141:203–209.
   PubMed Web of Science ®Google Scholar
• Mehta SC, Lai JC, Lu DR. 1996. Liposomal formulations containing sodium mercaptoundecahydrododecaborate (BSH) for boron neutron capture therapy. J Microencapsul 13:269–279.
   PubMed Web of Science ®Google Scholar
• Mehta SC, Lu DR. 1996. Targeted drug delivery for boron neutron capture therapy. Pharm Res 13:344–351.
   PubMedGoogle Scholar
• Nakamura H. 2009. Liposomal boron delivery for neutron capture therapy. Methods Enzymol 465:179–208.
   PubMed Web of Science ®Google Scholar
• New RRC. 1990. Liposomes. New York: Oxford University Press.
   Google Scholar
• Pan G, Oie S, Lu DR. 2004. Uptake of the carborane derivative of cholesteryl ester by glioma cancer cells is mediated through LDL receptors. Pharm Res 21:1257–1262.
   PubMedGoogle Scholar
• Peacock G, Sidwell R, Pan G, Oie S, Lu DR. 2004. In vitro uptake of a new cholesteryl carborane ester compound by human glioma cell lines. J Pharm Sci 93:13–19.
   PubMedGoogle Scholar
• Peacock GF, Ji B, Wang CK, Lu DR. 2003. Cell culture studies of a carborane cholesteryl ester with conventional and PEG liposomes. Drug Deliv 10:29–34.
   PubMed Web of Science ®Google Scholar
• Reginatto M, Goldhagen P. 1999. Maxed, a computer code for maximum entropy deconvolution of multisphere neutron spectrometer data. Health Physics 77:579–583.
   PubMed Web of Science ®Google Scholar
• Sampedro F, Partika J, Santalo P, Molins-Pujol AM, Bonal J, Perez-Soler R. 1994. Liposomes as carriers of different new lipophilic antitumour drugs: A preliminary report. J Microencapsul 11:309–318.
   PubMed Web of Science ®Google Scholar
• Schinazi RF, Hurwitz SJ, Liberman I, Glazkova Y, Mourier NS, Olson J, Keane T, et al. 2004. Tissue disposition of 5-o-carboranyluracil – a novel agent for the boron neutron capture therapy of prostate cancer. Nucleosides Nucleotides Nucleic Acids 23:291–306.
   PubMed Web of Science ®Google Scholar
• Sidwell RA. 2002. Extraction and analysis by HPLC of the novel compound BCH in formulations, cell culture, and animal tissue. Ph. D. Thesis. University of Georgia.
   Google Scholar
• Siegel R, Naishadham D, Jemal A. 2013. Cancer statistics, 2013. CA Cancer J Clin 63:11–30.
   PubMed Web of Science ®Google Scholar
• Soloway AH, Tjarks W, Barnum BA, Rong FG, Barth RF, Codogni IM, Wilson JG. 1998. The chemistry of neutron capture therapy. Chem Rev 98:1515–1562.
   PubMed Web of Science ®Google Scholar
• Thirumamagal BT, Zhao XB, Bandyopadhyaya AK, Naranyanasamy S, Johnsamuel J, Tiwari R, Golightly DW, et al. 2006. Receptor-targeted liposomal delivery of boron-containing cholesterol mimics for boron neutron capture therapy (BNCT). Bioconjug Chem 17:1141–1150.
   PubMed Web of Science ®Google Scholar
• Tilly N, Olsson P, Hartman T, Coderre J, Makar M, Malmquist J, Sjoberg S, et al. 1996. In vitro determination of toxicity, binding, retention, subcellular distribution and biological efficacy of the boron neutron capture agent DAC-1. Radiother Oncol 38:41–50.
   PubMed Web of Science ®Google Scholar
• Uehara S, Nikjoo H. 2006. Monte Carlo simulation of water radiolysis for low-energy charged particles. J Radiat Res 47:69–81.
   PubMed Web of Science ®Google Scholar
• Yasui L, Kroc T, Gladden S, Andorf C, Bux S, Hosmane N. 2012. Boron neutron capture in prostate cancer cells. Appl Radiat Isotopes 70:6–12.
   PubMedGoogle Scholar